Pharma Tech Outlook
" Synbio Technologies was decided as one of the Top 10 companies in 2020 that provide drug discovery and development services. "
-- Pharma Tech Outlook Magazine
A roadmap to innovate through DNA Technologies
Featured Services
- Reliable gene synthesis supplier
- ISO certified quality system
- Fast turnaround time & competitive price
- Any sequence is synthesizable
- Size up to 1014
- Controlled library available (Trimer, etc.)
- 4 sigma standards construction
(accuracy, uniformity & diversity, etc.) - From “writing” sequence to discover solution
- Made in USA, deliver globally
- Super coiled plasmid DNA preparation
- Optional endotoxin level (<0.005, 0.1EU/μg)
- Express & guaranteed output
- No species restriction
- Minimized off-target rate
- Broad range of activation
& interference libraries - One stop genome engineering
from design & edit to analyze
- Proprietary bio-design algorithm
- Artificial intelligence
based drug discovery - Cost effective & time effective
- Combination of in silicon design
& high throughput manufacture
- Sample flexibility
(cells, total RNA, cDNA) - High accuracy & reproducibility
- Large processing capacity
allows fast data analysis - From “reading” sequence to
antibody discovery solution
- Oligos / probes up to 200nt
- Standard oligos starting from $0.07/nt
- ISO9001 & ISO13485 certified manufacture
- Multiple high quality labelling
- Free NGTM codon optimization
- Bacterial, yeast, insect &
mammalian protein expression system - Full spectrum of peptide modifications
- High quality, time effective & low cost
Trusted by Over 2000 Scientists Worldwide
RiceTec
" We are happy with your service. In order to establish a good collaboration,we’d like to open a charge account with you for future payments. "
——Venu Reddyvari Channarayappa, RiceTec Inc., USA
Stanford University
" Synbio Technologies has a very professional team who work with us closely during the projects. I am impressed with your resourcefulness, timely follow-ups and updates. Thank you! "
——Dr. Saumya Saurabh, Stanford University, USA
The University Of Iowa
" We were very impressed with the service we received from Synbio Technologies and would like to do business with them in the future. "
——Dr. Madeline A. Shea, University of Iowa, USA
Biogen Inc.
" Synbio Technologies is my favorite company in synthetic biology, better than some of the much bigger ones in the industry."
——Zhu Z., Biogen Inc., USA
About Us
Founded in 2013 by a group of passionate synthetic biologists with decades of industry experience and a proven track record of delivering cost-effective DNA solutions, Synbio Technologies is incorporated with a single mission in mind to empower scientific discoveries and drug innovation by providing the most advanced and cost-effective DNA technology platform. The company has developed a full range of DNA reading (sequencing), DNA writing (synthesis) and DNA editing (engineering) capabilities and delivered satisfactory solutions to global researchers for various applications, including diagnostic DNA probes, precision medicine, protein production, antibody discovery, vaccine development, novel enzymes, molecular breeding and biofuel implication etc. The company has over 250 scientific staff and its state of the art production facility is certified with the highest DNA manufacturing standards (ISO9001 & ISO13485).